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Blood is often cited as the most informative form of evidence at a violent crime scene. 
DNA analysis enables the identification of individuals involved in a crime whilst blood 
pattern analysis enables the reconstruction of a crime scene. Prior to analysis, potential 
bloodstains found at a crime scene are processed via observation, documentation, 
followed by presumptive testing. This screening process eliminates substances that have 
a similar appearance to human blood therefore ensuring that time and resources are not 
wasted on samples with little or no forensic value. 
 
The ABACard® HemaTrace® kit is a lateral flow immunochromatographic assay that 
targets human haemoglobin using antibodies and is used by the Western Australia (WA) 
Police as a test for the identification of human blood. However, WA Police officers have 
noted that in the northern regions of Western Australia, HemaTrace® kits have resulted in 
false negatives. It was postulated that this is due to prolonged exposure of the 
HemaTrace® kits to elevated storage temperatures resulting in a decrease in the 
HemaTrace® kit sensitivity and efficacy. However, a temperature stress test on 
HemaTrace has yet to be reported in the scientific literature and thus this hypothesis 
remains inconclusive. Thus, this literature review aims to critically assess the current 
literature pertaining to the HemaTrace® kits with emphasis on the sensitivity, specificity 
and robustness of the kits. As there are currently no studies that have investigated the 
effects of temperature on the performance of ABACard® HemaTrace® kit, this literature 
review will explore temperature studies on antibodies and other lateral flow 
immunochromatographic assays in order to postulate the effects of temperature on the 
HemaTrace® kits. Lastly, this literature review will outline parameters for potential 
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research in order to evaluate whether elevated temperature exposure for prolonged 




Blood is one of the most common and valuable forms of biological evidence found at a 
crime scene.1 DNA analysis of a blood sample could potentially identify individuals 
involved in the crime.2 Alternatively, Blood Pattern Analysis enables the sequencing and 
reconstruction of blood letting events.3 Thus, it is critical that human blood is correctly 
identified at crime scenes during a forensic investigations. To do this, potential 
bloodstains found at a crime scene are selected based on visual and contextual cues. 
However, many substances share a similar appearances to bloodstains and animal blood 
samples are potentially irrelevant to the crimes committed.4 Thus, this step is often 
shortly followed by presumptive testing of the potential bloodstain. 
 
The ABACard® HemaTrace® kit is an immunological presumptive test that utilises 
antibodies to target human heamoglobin present in red blood cells.5 This kit has been 
shown to be highly sensitive and specific, with minimal cross reactivity and thus is used by 
the Western Australia (WA) Police as a test for the identification human blood.4 However, 
WA Police officers have reported that the ABACard® HemaTrace® kits used in northern 
WA have a tendency to result in false negatives.6 This is potentially detrimental to an 
investigation as this could result in the exclusion of vital forensic evidence, hindering the 
progress of an investigation 
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It was postulated that this was potentially due to the higher temperatures experienced in 
the northern regions of WA, as it is not uncommon for daily temperatures to exceed 40°C 
during the summer months.7 Two studies conducted by, Evans8 and Teaghan9 attempted 
to test this hypothesis by evaluating whether exposure of bloodstains to elevated 
temperatures could be responsible for the HemaTrace® false negative results. This was 
based on the assumption that elevated temperature exposure could potentially denature 
haemoglobin beyond the recognition of the HemaTrace® antibodies. However, it was 
noted that false negatives only began occurring when bloodstains were exposed to 
temperatures at 80°C.9 As it is rare that bloodstains at a crime scene would be exposed to 
such extreme temperatures, this hypothesis was deemed unsuitable to explain the 
occurrences of the HemaTrace® false negative results. 
 
Another factor that could potentially explain the occurences of the false negative results 
is that elevated temperature exposure of the HemaTrace® kits themselves, rather than 
the bloodstains, could be responsible for the false negative results. A study conducted by 
Dadour et al 10, in Perth, WA, noted the temperature inside the cabin of a vehicle was 
able to exceed the outside ambient temperature by 20-30°C. Thus, HemaTrace® kits 
stored in police vehicles are potentially exposed to temperatures up to 60°C. This is 
further exacerbated as the ABACard® HemaTrace® kits can be stored in police vehicles for 
months prior to use.6 However, this has yet to be tested and thus remains to be 
concluded. 
 
The ABACard® HemaTrace® kit operates based on antibody binding mechanisms.5 Thus, it 
is postulated that elevated temperature exposure to the HemaTrace® kits could denature 
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the antibodies in the kits resulting in protein unfolding of the antibody structure.11 This 
could affect the ability of the antibodies to bind to haemoglobin molecules in blood 
samples resulting in the false negative results. However, there have been no reported 
studies on the effects of temperature on the HemaTrace® kits in the scientific literature. 
This literature review aims to evaluate this hypothesis by exploring temperature studies 
on antibodies and other lateral flow immmunochromatographic assays in order to 
postulate the effects of temperature on the ABACard® HemaTrace® kits.  Furthermore, 
this literature review will aid in the determination of an experimental design flow in order 
to address this research gap. The results of such a study could provide information on 
suitable storage conditions for the HemaTrace kits and potentially provide an adequate 




This section aims to describe the mechanism in which the ABACard® HemaTrace® kits 
function. This will be done by evaluating the current literature pertaining to HemaTrace® 
with particular emphasis on the sensitivity and specificity of the kit. The second aim is to 
understand the potential effects of temperature on the HemaTrace® kits. This will be 






2.1 Composition of Blood 
Blood is a complex colloid suspension comprising of blood cells, proteins and amino acids 
suspended in a fluid matrix called plasma. The three major physiological roles of blood 
are: (i) transportation of gases, nutrients, hormones and waste products; (ii) regulation of 
temperature, pH and water content; (iii) protects the body against infection via the 
immune response. Through centrifugation, blood can be separated into four main 
components, which are plasma, platelets, white blood cells (WBCs) and red blood cells 
(RBCs).12 In DNA analysis, WBCs are integral for STR profiling as they are the only mature 
nucleated blood cells.2 In contrast, presumptive tests for blood target RBCs due to the 
abundance of haemoglobin within these cells.13 
 
In a healthy individual, RBCs account for 37-52% of the total blood volume.14 This 
percentage is known as the haematocrit and can vary depending on race, age, sex, 
altitude and smoking.15 Red blood cells are non-nucleated, circular, biconcave cells with a 
diameter of approximately 7.5μm.14 The main function of the RBC is for gas transport 
throughout the body. This is primarily done using the protein haemoglobin, which 
constitutes 97% of the RBCs’ dry content.16 
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Figure 1:  Circular biconcave structure of red blood cells (image from [14]) 
 
2.2 Human Haemoglobin 
Haemoglobin acts as a carrier to transport oxygen from the lungs to tissue and the 
removal of carbon dioxide from tissue to be expelled in the lungs.14 A single haemoglobin 
molecule is comprised of an aggregate of four globin protein units, each associated with a 




Figure 2: Aggregation of four haemoglobin subunits, forming a tetrameric haemoglobin molecule 
(Image from [17]) 
 
 
The haem group is responsible for the oxygen carrier capabilities of haemoglobin. Haem 
is comprised of a ferrous ion (Fe2+) and a protoporphyrin IX ring. 18 Synthesis of the 
protoporphyrin ring is regulated by an enzyme, δ-aminolaevulinic acid synthase, within 
the mitochondria.19 The ferrous ion (Fe2+) is centralised in the protoporphyrin ring by 
binding to four nitrogen atoms (Figure 3). Two additional bonds are formed with the 
ferrous ion that are integral to haemoglobin function.16 The first is reversible binding of 
an oxygen molecule to the ferrous ion, allowing haemoglobin to act as an oxygen carrier. 
The second bond formed by the ferrous ion mediates this process. The ferrous ion forms 
a bond with the associated globin protein on the histidine F8 residue located on residue 
87 and residue 92 of the alpha and beta globin subunits respectively.20 The function of 
this bond is two-fold. First, the globin protein prevents oxidation of the ferrous ion (Fe2+) 
into a ferric state (Fe3+) as haem in the ferric state will result in permanent binding of the 
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oxygen molecule. The second function is evident when oxygen is bound to the ferrous ion 
in haem, this results in a conformational change in the globin protein resulting in an 
increase in oxygen binding efficiency to haemoglobin, known as the allosteric effect.16 
 
 
Figure 3: Structure of heam comprising of a centralised ferrous (Fe2+) ion within a protophrpyrin 
IX ring (Image from [16]). 
 
The protein components of haemoglobin are represented by the four globin subunits.16 
For adult human haemoglobin, this consist of a pair of alpha globin subunits and a pair of 
beta globin subunits, known as the α-chain and β-chain respectively. The α-chain spans 
142 amino acid residues whilst the β-chain spans 147 amino acid residues.20 The 
secondary structure of both of the proteins consists of coiled structures known as α-
helices (Figure 4). The α-helix structures fold upon itself and each subunit associates itself 
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with a haem molecule to form the tertiary structure of each globin subunit. The four 
globin subunits then bind together via hydrophobic interactions to form the complete 
tetrameric form of haemoglobin (Figure 4). 21 
 
Figure 4: 3-D Haemoglobin structure. Red: Alpha globin subunits; Blue: Beta globin subunits; Grey: 
Protoporphyrin ring containing ferrous (Fe2+) ion (Image adapted from [21]). 
 
2.2.1 Human Haemoglobin Variants 
Variations of the haemoglobin composition are presented throughout different stages of 
healthy human development.16 A summary of the multiple haemoglobin variants and its 
occurrences are summarised in Table 1. Briefly, the tetrameric haemoglobin protein can 
be comprised of a combination of α, β, γ, δ, ε, or ζ subunit pairs. In an adult, the α2β2 
combination constitutes 97.5% of the total haemoglobin whilst the remainder is in the 








isoforms of adult haemoglobin can be detected by the HemaTrace® kit.5 Furthermore, 
embryonic and foetal bloodstains are not commonly found at crime scenes. Thus, the 
ABACard® HemaTrace® is an adequate kit for the forensic detection of bloodstains. 
 
Table 1: Human haemoglobin isoforms present throughout healthy human development 
(Adapted from [16]). 










2.2.2 Haemoglobin Degradation 
Haemoglobin can exist in various forms known as haemoglobin derivatives. In vivo 
haemoglobin is mainly present in two forms: (i) Deoxyhaemoglobin: unbound to oxygen; 
(ii) Oxyhaemoglobin: saturated with oxygen.14 Small amounts of oxyhaemoglobin in blood 
can auto-oxidise into methaemoglobin, resulting in the oxidation of the ferrous (Fe2+) ion 
into a ferric (Fe3+) state. However, in vivo, an enzyme, cytochrome b5, reduces 
methaemoglobin back into deoxyhaemoglobin.19 In a healthy individual, methaemoglobin 
only accounts for approximately 1% of the haemoglobin derivitives.22 
 
Blood at crime scenes is located ex vivo and becomes completely saturated with oxygen 
resulting in the formation of oxyhaemoglobin.22 This is due to the high partial pressure of 
oxygen in atmospheric air (~160mm Hg).14 As the availability of cytochrome b5 decreases 
ex vivo, oxyhaemoglobin will auto-oxidise into methaemoglobin. Over time, an internal 
conformational change in the haem group of methaemoglobin results in methaemoglobin 
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denaturation into hemichrome.22 Thus, ex vivo, haemoglobin follows a sequential 
degradation from oxyhaemoglobin to methaemoglobin to hemichrome (Figure 5). 
 
 




Marrone and Ballantyne23 monitored the changes in human haemoglobin derivatives over 
time using visible spectroscopy. It was noted that for dry haemoglobin samples, the sum 
of the three haemoglobin derivatives (oxyhaemoglobin, methaemoglobin and 
hemichrome) decreased with age (Figure 6). This is indicative of a fourth haemoglobin 
derivative, which was hypothesised to be ferrylhaemoglobin or choleglobin.23 However, 
the spectral evidence did not indicate any presence of either ferrylglobin or choleglobin. 
Thus, it is possible that a fourth unknown haemoglobin derivative is involved in the 
haemoglobin degradation process, which is undetectable using visible spectroscopy. 
 
 




Figure 6: Detection of haemoglobin derivatives, oxyhaemoglobin (), methaemoglobin(), and 
hemichrome (Δ) from dry haemoglobin samples using visible spectroscopy over a period of 2200 
hours (Image from [23]). 
 
The ABACard® HemaTrace® kit utilises antibodies to target the α-chain of haemoglobin. 
However, there has yet to be any evidence in the literature to suggest whether the 
conformational changes that occur during the degradation process of haemoglobin will 
affect the efficacy of the HemaTrace® kit. Thus, this is an area that warrants future study. 
 
2.3 ABACard® HemaTrace® 
The ABACard® HemaTrace® is a sandwich format lateral flow immunochromatographic 
assay that utilises antibodies to target the alpha chain of human haemoglobin.23 Similar 














overlapping strips arranged in a plastic housing.25 These consist of the sample pad, 
conjugate pad, nitrocellulose membrane and absorbent pad (Figure 7). Table 2 




Figure 7: Schematic for HemaTrace® and other lateral flow immunochromatographic assays 












Table 2: Summary of strip components and function for the ABACard® HemaTrace®. (Information 
collated from [26],[27]). 





Buffer salts, blocking 
agents, detergentsa 
To ensure that samples are 
maintained at optimal 











Contains the biorecognition 
molecule conjugated to a 
labelling dye that is 
responsible for the production 








Two spatially separated sets of 
antibodies where one acts as  
test for the presence of 
haemoglobin whilst the other 
acts as an internal control for 
the HemaTrace® kit 
Absorbent 
pad Cellulose filter None 
Acts as a reservoir to prevent 
backflow of the extract 
therefore reducing 
background noise resulting 
from unbound labelling dyes 
a - As HemaTrace® is a commercial kit, the exact components are not publically known 
 
Prior to HemaTrace® testing, blood samples are diluted in the HemaTrace® extraction 
buffer. This promotes haemolysis to release haemoglobin from RBCs.24 To begin the 
HemaTrace® test, the extract is placed into the Sample Well (Figure 8). Haemoglobin in 
the extract binds to mobile monoclonal antihuman-Hb antibodies-dye conjugates in the 
conjugate pad resulting in the formation of mobile antigen-antibody-dye complexes. The 
mobile complexes diffuse along the nitrocellulose membrane to the Test Area containing 
immobile polyclonal antihuman-Hb antibodies. The immobilised polyclonal antibodies 
bind to the mobile complexes to form an antibody-antigen-antibody sandwich, hence the 
name sandwich format. This results in the accumulation of the conjugated dye at the Test 
Area resulting in a pink band. Excess mobile monoclonal antihuman-Hb antibodies 
migrate past the Test Area to the Control Area. Immobilised anti Ig-antibodies at the 
 21 
Control Area bind to the excess mobile monoclonal antihuman-Hb antibodies resulting in 
the accumulation of the conjugated dye. Thus, a second pink band is formed that acts as 
an internal control for the HemaTrace® kit (Figure 8).24 
 
Figure 8: Mechanism of ABACard® HemaTrace® in the presence of human haemoglobin. (Image 
from [24]). 
 
According to the manufacturer’s protocol, HemaTrace® results should be recorded within 
10 minutes after application of extract to the sample well. This is to prevent backflow of 
the extract, which may result in false positives.5 The results of the HemaTrace® kit is 
qualitative, where results are recorded as positive, negative or inconclusive. A pink band 
at both the Test (T) and Control (C) regions indicates a positive result. A negative result is 
indicated by the absence of a pink band at the ‘T’ region with the presence of a band at 
the ‘C’ region. A result is deemed inconclusive if no band appears at the ‘C’ region 
regardless if a band is present or absent at the ‘T’ region (Figure 9).5 
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Figure 9: Interpretation of ABACard® HemaTrace® results. (Image from [5]). 
 
As HemaTrace® is a sandwich format immunoassay, the HemaTrace® kit suffers from false 
negatives at high haemoglobin concentrations due to the High Dose Hook Effect.5 At 
these concentrations, the mobile monoclonal antibodies become saturated with 
haemoglobin, generating mobile antigen-antibody-dye complexes with excess unbound 
haemoglobin. The excess unbound haemoglobin is smaller than the antigen-antibody-dye 
complexes and thus will diffuse down the nitrocellulose membrane at a faster rate. This 
results in unbound haemoglobin binding to the immobilised polyclonal antihuman-Hb 
antibodies first therefore occupying the binding sites of the antibodies at the Test line.28, 
29 Thus, the mobile antigen-antibody-dye complexes are unable to bind to the Test area, 
allowing the complexes to migrate to the Control area. In contrast to normal HemaTrace 
function, the antigen-antibody-dye complexes now bind to the immobilised anti Ig-
antibodies at the Control area. This results in a pink band only at the Control area giving 
the appearance of a negative result.24 However, according to the manufacturers, the High 







2.3.1 ABACard® HemaTrace® Sensitivity 
A number of sensitivity studies have been conducted on the ABACard® HemaTrace® kit.5, 
24, 30-33 An overview of all sensitivity studies on HemaTrace® is summarised in Table 3. 
However, these studies have shown results inconsistent with the Technical Information 
Sheet provided by the manufacturers, Abacus Diagnostics.5 The Technical Information 
Sheet provided by Abacus Diagnostics has noted that the minimum haemoglobin 
concentration detectable by the HemaTrace® kit is 0.05μg/mL.5 However, Johnston et al 
24 and Kristaly et al 32 have reported a minimum detection limit that was one magnitude 
higher than that indicated by Abacus Diagnostics, with a minimum detection limit of 
0.26μg/mL and 0.125μg/mL respectively. In contrast, Swander and Stites33 have reported 
a minimum detection limit of 0.008μg/mL, which was one magnitude lower than what 
was reported by Abacus Diagnostics. A detailed review of these studies has revealed 
three potential areas that could result in the difference in reported sensitivities. These 
were differences in haemoglobin concentration estimations, differences in HemaTrace® 










Table 3: Summary of ABACard® HemaTrace® sensitivity studies. 
Study Sample deposition Extraction technique 























1:10 000 000 none 
Johnston et al*24 
Blood deposited 
immediately into sterile 
water 
Extracted using 








1:2 000 000 0.07 
Blood diluted with sterile 









Atkinson et al31 
Blood diluted with sterile 
water and deposited on 
white cotton 









immediately into sterile 
water 
Extracted using 
sterile water 1:262 144 none 
Kristaly et al32 
Blood deposited 
immediately into sterile 
water 
Extracted using 


















1:16 777 216 0.008 
Blood diluted with sterile 
water and deposited on 
white cotton 
Extracted using 2mL 
HemaTrace® 
extraction buffer 
1:32 768a n/ab 
* - used heparin and EDTA anticoagulated blood. 
a - dilution factor of diluted bloodstain. Does not include dilution during  extraction step. 
b – unable to estimate Hb concentration as only a portion of the bloodstain on the substrate was extracted. 
 25 
The first possible explanation for the sensitivity discrepancies is that the sensitivity 
studies used haemoglobin concentration estimates rather than measured absolute 
haemoglobin concentrations. Johnston et al24 estimated the haemoglobin concentration 
of the neat blood sample to be 130g/L by using the average haemoglobin content of a 
healthy female. However, haemoglobin concentration of an individual can vary depending 
on race, age, sex, altitude and smoking.15 Thus, this estimate is unlikely to be accurate. 
Similarly, Swander and Stites33 and Kristaly et al32 also estimated the haemoglobin 
concentration of the neat blood sample to determine the haemoglobin concentrations in 
the diluted samples. However, both studies failed to outline the methodology used to 
determine these values. To overcome this issue, future studies attempting to report 
haemoglobin concentrations as an indicator for HemaTrace® sensitivity should attempt to 
accurately measure the haemoglobin concentration of the neat blood samples. This can 
be done using flow cytometry by performing a Complete Blood Count15 or ideally using 
high performance liquid chromatography22. 
 
The second explanation is that some studies used sterile water instead of the 
HemaTrace® extraction buffer to extract haemoglobin from red blood cells.24, 31-32 A 
comparison of the results between the two extraction methods revealed that extraction 
using the HemaTrace® extraction buffer often resulted in sensitivity readings one 
magnitude higher than extraction using sterile water (Table 3). As HemaTrace® is a 
commercial kit, the exact contents of the extraction buffer are not publically known. 
However, Johnston et al24 has noted that the extraction buffer contains Tris buffer saline. 
As Tris buffer has been previously shown to increase membrane permeability34, the Tris 
buffer potentially increases the sensitivity of the HemaTrace kit by facilitating haemolysis. 
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Alternatively, the Tris buffer could merely act as a pH buffer to maintain the pH and ionic 
strength of the blood sample during HemaTrace testing.26 However, until the full contents 
of the extraction buffer are known, this cannot be concluded.  
 
Lastly, the differences in HemaTrace® sensitivity could potentially arise from different 
dilution protocols during extraction. Johnston et al24, Atkinson et al31 and Swander and 
Stites33 diluted blood in sterile water which was then deposited on a cotton swatch. This 
resulted in a threefold magnitude reduction in HemaTrace sensitivity as blood samples 
were diluted once using sterile water followed by a second dilution during extraction in 
the HemaTrace® extraction buffer. To illustrate that the reduction in sensitivity was due 
to the two-step dilution, Atkinson et al31 extracted the diluted blood samples in 300μL of 
HemaTrace® extraction buffer instead of the conventional 2mL, resulting in a four-fold 
increase in HemaTrace sensitivity. Thus, it is important that forensic examiners are aware 
that the HemaTrace® extraction buffer acts as a diluent as extreme dilutions of the 
extract could result in false negatives. 
 
2.3.2 ABACard® HemaTrace® Specificity 
A common trade-off for increased sensitivity is a reduction in specificity. For the 
HemaTrace® kit, this has been demonstrated in specificity studies on human bodily fluids. 
Horjan et al, Kristaly et al, Johnston et al and Reynolds4, 24, 30, 32 tested saliva, semen, 
faeces, vaginal secretions and urine samples, which resulted in HemaTrace® false 
positives due to trace haemoglobin levels in the bodily fluids (Table 4). A contrasting 
study by Swander and Stites33 noted that saliva and urine samples did not produce false 
positives. However, Swander and Stites failed to provide an outline of the methodology 
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employed for saliva and urine testing. As seen in Kristaly et al32, HemaTrace® kits were 
only able to detect saliva and urine samples at 1:5 and 1:50 dilutions respectively. Thus, it 
is possible that the urine and saliva samples in the Swander and Stites33 study was 
potentially too dilute. However, without a clear outline of the methodology employed in 
the Swanders and Stites study, this cannot be concluded. It was hypothesised that the 
false positive results seen when testing other human bodily fluids is a result of trace 
amounts of haemoglobin in these fluid.24,30,32 Thus, although the ABACard® HemaTrace® 
kit is specific for haemoglobin, due to the high sensitivity of the kit, the ABACard® 
HemaTrace® kit may not be specific for blood. 
Table 4: Summary of ABACard® HemaTrace® bodily fluid specificity studies. 
Study 
Bodily fluid specificity 
Human bodily 
fluids tested Results 
HemaTrace® Technical 
Information Sheet5 n/a 
Trace amounts of Hb in urine, semen, 
faeces, saliva, vaginal secretions and 
perspiration can result in false positives 
Horjan et al30 Saliva Saliva resulted in HemaTrace® false positive 
Reynolds4 Saliva, urine Saliva and urine resulted in HemaTrace® false positive 






Oral, vaginal, anal and rectal swabs 
resulted in HemaTrace® false positives 
Kristaly et al32 Semen, urine, saliva All three fluids resulted in false positives 
Swander and Stites33 Saliva, urine No false positives detected in saliva and urine samples 
 
Species specificity studies on HemaTrace® have demonstrated that HemaTrace produces 
false positives with higher primates and ferret blood samples2-5,24, 31-33. An overview of 
species specificity studies is illustrated in Table 5. A contrasting study by Kristaly et al32 
noted that ferret blood did not result in a false positive result. In the study conducted by 
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Atkinson et al31, it was noted that four drops of ferret blood placed into the sample well 
followed by two drops of extraction buffer, only produced a weak positive result. In order 
to show that this was not due to the high dose hook effect, one drop of ferret blood was 
diluted into 2mL of the HemaTrace® extraction buffer, which also produced a weak 
positive result. Thus, this is suggestive that the sensitivity of the HemaTrace® kit against 
ferret blood is potentially low. This may potentially provide a possible explanation for the 
negative result seen in Kristaly et al32. However, this cannot be concluded, as neither 
Kristaly et al32 nor Atkinson et al31 noted the dilution factors used to test the ferret blood 
samples. 
Table 5: Summary of ABACard® HemaTrace® species specificity studies.  
Study 
Species specificity 






Primates (anthropoideae) and 
ferret blood will result in a 
positive HemaTrace® result 
Reynolds4 Canine (dog), Equine (horse), Porcine (pig), Feline (cat) 
All animals tested negative. 
However, when animal blood was 
mixed with human blood, 
mixtures tested positive 
Johnston et 
al24 
Dog, Cat, Horse, Pig, Goat, Cow, Domestic ferret, 
cockatiel, Dall's sheep, European reindeer, Barbary 
ape, Mara, Wapiti (elk), Black footed ferret, 
Tamandua, Ring-tailed lemur, Snow leopard, Sable 
antelope, Boa constrictor, Trumpeter swan, 
Japanese macaque, Sumatran tiger, Chamois, 
African cheetah, African elephant, Grevy's zebra, 
Olive baboon, Canadian lynx, Harbour seal, Striped 
skunk, Racoon, Red fox, Moose, San Clemente 
Loggerhead Shrike, Gray Jay, Eastern wolf, Black 
bear 
Only higher primates and ferrets 




Cat, Kangaroo, Horse, Dog, Bull, Sheep, Pig, Fowl, 
Python, Possum, Wallaby, Monkey, Ferret 
Only the monkey and ferret blood 
samples resulted in false positives 
Kristaly et 
al32 
Skunk, Rabbit, Chicken, Porcupine, Snake, Lion, 
Waterbuck, Fox, Tortoise, Elephant, Pig, Flamingo, 
Camel, Horse, Spoonbill, Dog, Cat, Ferret 
All animal blood samples tested 
negative including ferret blood 
samples 
Swander and 
Stites33 Deer, Cow, Pig, Horse, Dog, Cat, 
All animal blood samples tested 
negative 
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A possible explanation for the false positive results for higher primates and ferret blood 
was proposed by Johnston et al.24 It was stated that the amino acid sequence TNAVAHV 
that is located on residues 67-73 on the α-chain of the human haemoglobin protein could 
potentially serve as an epitope for monoclonal antibody recognition. This region was 
noted to show variability between human and commonly encountered animal 
haemoglobins. Also, this sequence was noted to be sufficiently different from the 
corresponding amino acid sequence in rabbits and mice to enable an immunogenic 
reaction, which is required for the production of monoclonal and polyclonal antibodies.35 
However, no evidence or references were provided to support this statements in the 
study. Thus to reappraise this statement, the author of this literature review conducted a 
GenBank search to compare the alpha chain haemoglobin amino acid sequences between 
humans, higher primates, ferrets and other commonly found household animals.20 The 
gorilla and chimpanzee were used as a representative for higher primates. The sequence 
for cats, dogs and rats were used, as these are common household animals. Lastly, 
chicken cow and pig sequences were analysed, as these are common meat products 
found in kitchens. A ClustalW alignment, using the Unipro UGENE 1.27 software, revealed 
that the TNAVAHV sequence is shared between humans, gorillas, chimpanzees and 
ferrets whilst dogs, cats, rats, chickens, cows and pigs showed variability in the amino acid 
sequence at this region (Figure 10). Thus, this supports the hypothesis proposed by 
Johnston et al.24 However, as the antibodies in the HemaTrace® kit are not publically 





Figure 10: ClustalW alignment of the alpha chain amino acid sequence of haemoglobin for 
multiple animal species using Unipro UGENE 1.27 software. 
 
In conclusion, the ABACard® HemaTrace® kit is neither specific to human samples nor 
blood samples. Thus, there has been some debate in the literature as to whether 
HemaTrace® is a confirmatory or presumptive test for the identification of human blood. 
One justification for the confirmatory test argument is that ferret and higher primate 
blood samples are unlikely to be found at the majority of crime scenes. Furthermore, 
bloodstains at a crime scene are selected based on visual cues and contextual cues whilst 
a Kastle-Meyer test is conducted prior to HemaTrace testing to eliminate the inclusion of 
other human bodily fluids in the HemaTrace results.31 Thus, the consideration of the 
HemaTrace® kit as a confirmatory test for human blood at crime scenes is somewhat 
practical. This was shown in case studies where the specificity of the ABACard® 
HemaTrace® kit was sufficient to be able to differentiate human blood from animal blood 
at crime scenes. Furthermore, HemaTrace® kits were able to identify human blood 






2.4 Antibody Structure and Function 
The ABACard® HemaTrace® utilises antibodies, also known as immunoglobulins, to target 
the α-chain of human haemoglobin.24 In vivo, there are four main immunoglobin isotypes 
known as, IgG, IgM, IgE, IgD and IgA.35 However, for commercial immunoassays such as 
the ABACard® HemaTrace®, the IgG isotype is preferentially used as IgG antibodies have 
been shown to have long resident half-lives, thus resulting in longer shelf lives.36  
 
A typical IgG antibody molecule is composed of four polypeptide chains. This consists of 
two identical Heavy chains and two identical Light chains bound together by disulphide 
bridges (Figure 11).35 These four polypeptides can be functionally broken down and 
grouped together into different segments consisting of two identical Fab segments and a 
single Fc segment. This results in a Y-shaped conformation where the antigen binding 
sites are located at the far end of the Fab segments (Figure 11).37  
 







The secondary structure of the Fab segment is comprised of β-strands that flank three 
hyper variable regions in the Light chain and Heavy chain each.35 The β-strand structure, 
folds onto itself to form the tertiary and quaternary structure of the Fab segment. A 
result of this folding is that the six hypervariable domains from the Heavy and Light chains 
are concentrated at the outer edge of the antigen binding site (Figure 12). This region is 
responsible for the specificity and binding capabilities of the IgG antibody and is called 
the Complementarity-determining region (CDR).35 
 
 
Figure 12: Formation of the CDR of the Light Chain at the antigen-binding site. (a) Secondary 
structure, (b) Tertiary structure and (c) Quaternary structure of the Light Chain CDR (Image 
adapted from [35]) 
 
Antibody binding to an antigen is reliant on shape and chemical complementarity of the 
antigens and the CDR of the antibody.35 Chemical complementarity is responsible for the 
actual binding of the antibody to the antigen where amino acid side chains form 
reversible non-covalent interactions between the antigen binding site and the antigen. 
Shape complementarity ensures that the amino acid side chains in the antibody and the 
antigen are in the appropriate orientation for binding.38 Degradative agents such as 
temperature have been known to denature proteins resulting in a change in protein 
folding conformation.35 Thus, for the ABACard® HemaTrace®, exposure to elevated 
temperatures could potentially result in a conformational change in the CDRs of the 







2.5 Elevated Temperature Exposure 
The effects of temperature on the ABACard® HemaTrace® has yet to be studied. Thus, 
this section will aim to postulate the effects of temperature on HemaTrace® by evaluating 
temperature studies on antibodies and other lateral flow immunochromatographic 
assays. 
 
2.5.1 Temperature and antibodies 
ABACard® HemaTrace® kits stored in police vehicles are potentially exposed to elevated 
temperatures6, which could potentially lead to antibody denaturation. A study by Vemeer 
and Norde39 used differential scanning calorimetry (DSC) to monitor the changes in IgG 
antibodies in response to temperature. They found that at 61°C, the Fab segment 
denatures irreversibly followed by Fc segment denaturation at 71°C. In order to measure 
the rate of Fab segment denaturation, Vemeer and Norde39 incubated IgG antibodies at 
temperatures ranging from 41°C to 70°C and measured heat flow using isothermal 
calorimetry. Similar to the DSC results, antibodies denatured at approximately 60°C. 
However, it was also noted that at 55°C, IgG antibodies denatured at the Fab segment but 
at a much slower rate, taking up to 25 hours for full denaturation. Thus, this showed that 
the level of antibody denaturation is dependant on both temperature and exposure 
duration. As antibody binding is dependant on shape complementarity of the Fab 
segment with the antigen, denaturation of the antibody at 55°C could potentially result in 
a change in antibody binding activity.35 However, Vemeer and Norde39 did not test the 
antibody reactivity after denaturation thus this remains to be concluded. 
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Johnstone et al40 evaluated the effects of temperature on the binding kinetics of four 
monoclonal antibodies using flow cytometry at temperatures ranging from 1°C to 37°C. It 
was found that for the majority of antibodies, an increase in temperature resulted in 
decrease in the antibody binding equilibrium constant. This indicated that at higher 
temperatures, antibodies were more likely to dissociate from their respective antigens. 
However, Johnstone et al40 noted that the decrease in antibody binding kinetics for the 
four monoclonal antibodies did not show a predictive pattern, indicating that different 
antibodies are affected differently by elevated temperature exposure.  
 
Labrousse et al41 and Imagawa et al42 studied the effects of temperature on IgG 
antibodies in regards to antibody reactivity and specificity. Both studies showed a similar 
trend where antibody reactivity increased with temperature. This is somewhat 
contrasting to the study by Johnstone et al40 that indicated that antibodies were more 
likely to dissociate from antigens at higher temperatures. However, Labrousse et al41 and 
Imagawa et al42 noted that the increase in antibody reactivity was also associated with a 
decrease in antibody specificity. Thus, this could potentially explain the difference seen 
between the Imagawa and Labrousse studies and the Johnstone et al study.40-42 
Additionally, Labrousse et al41 noted that at 56°C, antibody reactivity began to decrease. 
As noted by Vemeer and Norde39, this temperature coincides with the denaturation 
temperature of the Fab segment. Thus, it is possible that the Fab segment denaturation 
could contribute to the reduction in antibody reactivity. However, as both antibodies and 
antigens were incubated simultaneously at the experimental temperatures, Labrousse et 
al41 could not conclude whether the reduction in antibody reactivity was a result of 
antibody denaturation or antigen denaturation. 
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The literature thus far suggests that at temperatures above 55°C, antibody reactivity will 
reduce due to Fab denaturation. However, these studies evaluated antibodies in solution. 
In contrast, the ABACard® HemaTrace® antibodies are immobilised on a nitrocellulose 
membrane. Wang et al36 and Wu et al43 studied the effects of temperature on antibodies 
immobilised on paper by incubating the antibodies at temperatures ranging from 40°C to 
140°C. It was found that antibodies remained relatively stable at temperatures below 
80°C, showing only a slight reduction in antibody reactivity with exposure times up to 24 
hours (Figure 13). The stable temperature ranges noted in Wang et al36 and Wu et al43 are 
highly contrasting with what was reported by Vemeer and Norde.11 Thus, this suggests 
that the immobilisation of antibodies to a surface could potentially increase antibody 
resistance to denaturation at elevated temperatures. 
 
 
Figure 13: Influence of temperature and exposure time on antibodies immobilised on paper. Error 
bars give the standard deviation of the triplicates (Image from [36]) 
 
In conclusion, the current evidence indicates that elevated temperature exposure results 
in antibody denaturation, resulting in a reduction in antibody binding efficacy. Therefore 
the exposure of the HemaTrace® kits to elevated temperatures may result in a decrease 
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in antibody binding to haemoglobin resulting in a reduction in kit efficacy. However, 
different antibodies appear to respond differently to elevated temperature exposure. 
Furthermore, antibodies immobilised on paper have been shown to increase the stability 
of antibodies at higher temperatures. Thus as the antibodies used in the ABACard® 
HemaTrace® kit are not publically known, it is difficult to infer the exact effects of 
temperature on the HemaTrace® antibodies. Thus, this is a potential area for future 
research. 
2.5.2 Temperature and Lateral Flow Immunochromatographic 
Assays 
The ABACard® HemaTrace® kit is a sandwich format lateral flow immunochromatographic 
assay (LFIA).5 Thus, temperature studies done on other LFIAs could potentially provide 
insights on the possible effects of temperature on the HemaTrace® kits. 
 
A common approach to monitor the temperature stability of LFIAs is by quantitative 
measurement of the Test and Control band intensities (Figure 14).44-51 Peng et al44 noted 
that the Test line intensity correlates well with sample concentration. However, Li et al45 
indicated that pH, ionic strength and temperature variations could lead to variability in 
the Test line intensity. To overcome this, the majority of studies use the Control line as a 
normalising factor, thus using he ratio of the Test band intensity against the Control band 
intensity (T/C ratio) as a representation of target concentration.44-51 Furthermore, Liu et 
al46 and Alfonssi et al47 found that T/C ratio concentration measurements were 
comparable to liquid chromatography-mass spectrometry (LC-MS) concentration 
measurements (Figure 15).  
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Figure 14: Measurement of Test and Control band intensities of a lateral flow 




Figure 15: Correlation of results between C/T ratio concentration measurements and liquid 
chromatography-mass spectrometry (LC-MS) concentration measurements. Linear regression 
analysis showed good correlation between the methods(y = 1.07x – 0.2, R2 = 0.0990, n = 
24)(Image from [47]). 
 Control Test 
 38 
 
Peng et al44 conducted a study to evaluate the temperature stability of an LFIA used to 
detect clenbuterol in swine urine. It was found that when tested against a positive control 
sample of 5.0μg/L incubation of the LFIA at 60°C resulted in a steady decline of T/C ratio 
with the duration of temperature exposure. A similar study by Di Nardo et al48 showed 
that at room temperature and 4°C, the LFIA tested took 180 days to degrade to unreliable 
levels. Incubation of the LFIA at 37°C took a week to reach similar levels. Thus this showed 
that temperature exposure reduced the efficacy of the LFIA kits by accelerating the rate 
of degradation of the LFIA kits. 
 
Incidentally, exposure of LFIAs to elevated temperatures is routinely used to determine 
kit shelf life.52 This is known as an accelerated aging test. A typical accelerated aging test 
subjects LFIAs to temperatures 15°C or more above the recommended storage 
temperature.52 By monitoring the change in T/C ratio of the LFIA kit with time at elevated 
temperatures, the LFIA shelf life can be calculated using the Arrhenius equation. The 
equation gives the rate constant of LFIA degradation, k, which is influenced by the 
temperature, T, and the activation energy Ea. The Arrhenius equation is shown below 




The rate constant, k, can then be used to calculate the duration an LFIA kit remains viable 
at a given temperature. 
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Thus, for the ABACard® HemaTrace®, exposure to elevated temperatures is expected to 
result in a decrease in kit efficacy. However, without experimental evidence, this cannot 
be concluded. Furthermore, a study by Peng et al44 demonstrated that addition of 
stabilising compounds such as WellChampion™ (Kem-En-Tec Diagnostics) can increase the 
thermal stability of LFIAs. Thus, as the components of the HemaTrace® kits are not 
publically known, the effects of temperature on HemaTrace® remains to be elucidated. 
 
 
3.0 EXPERIMENTAL DESIGN ELEMENTS 
3.1 Temperature Conditions in Parked Vehicles 
It has been reported that the high temperatures experienced in the northern regions of 
WA may be responsible for the HemaTrace® false negatives reported by WA Police 
officers.6 A report by the Bureau of Meteorology7 in 2017 showed that a northern town, 
Broome, had ambient temperatures consistently higher than in Perth (Table 6). 
Furthermore, during the summer months, it was not uncommon for temperatures to 















Table 6: A summary of monthly temperatures recorded for Perth (International Airport Station) 
and Broome (Airport Station) during 2016 as reported by the Bureau of Meteorology. 

















January  32.4 43.0 34.4 40.5 
February 32.8 42.7 34.2 39.6 
March 30.0 40.1 35.0 40.8 
April 25.0 33.9 36.8 41.0 
May 20.8 26.2 32.0 38.2 
June 18.5 24.7 31.1 34.0 
July 17.7 22.6 30.9 35.1 
August 17.5 22.3 30.7 34.8 
September 18.5 23.4 32.3 37.1 
October 22.0 32.6 34.1 40.1 
November 28.3 38.2 34.8 42.6 
December 29.3 42.8 33.8 41.9 
 
Dadour et al10 conducted a study looking at the temperatures experienced inside parked 
vehicles in Perth, WA. It was found that the temperature inside the cabin of a vehicle was 
able to exceed the outside ambient temperature by 20-30°C. Thus an appropriate 
temperature range for HemaTrace® testing would be temperatures ranging from 
approximately 40-70°C. 
 
Interestingly, Dadour et al10 also demonstrated that the internal temperature of a vehicle 
was influenced by the amount of solar radiation that was able to penetrate into the cabin. 
The orientation and level of shading of the vehicle also influenced the internal 
temperature, as both would determine the level of solar radiation exposure. Car colour 
and ventilation also had an effect on the internal cabin temperature where white cars 
were found to have lower average internal temperatures than black cars. Furthermore, it 
was noted that the trunk of the vehicle had a temperature that was significantly lower 
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than the cabin temperature but higher than the ambient temperature (Figure 16). As 
multiple variables appear to be affecting the internal temperature of a car, temperature 
data loggers could be used to record temperatures experienced by the ABACard® 
HemaTrace® kits stored in police vehicles. This would enable the determination of a more 
accurate temperature range for testing, in order to simulate the storage conditions 
experienced by the HemaTrace® kits in WA Police vehicles. 
 
 
Figure 16: Ambient outside air temperature (the lowest curve), temperature measured in 
the trunk (middle curve) and temperature measure in the cabin (upper curve) of a parked 








3.2 Exposure Time 
 
The degradative impact of temperature on LFIAs is dependent on the level and exposure 
time. King et al53 provided a recommended outline for stability testing of ligand binding 
assays. It was noted that an ideal study would employ a real-time stability test by 
incubating the kits at the desired storage temperature until the kits failed to produce the 
expected results. According to the HemaTrace® Technical Sheet provided by Abacus 
Diagnostic, the HemaTrace® kits, upon receipt, should have a shelf life of approximately 
one year, with a recommended storage temperature of 28°C and below.5 Therefore, an 
ideal study looking at the effects of temperature on the HemaTrace® kits should monitor 
the sensitivity of the kits throughout its shelf life (i.e. one year).  
 
However, due to practical reasons, an accelerated stability test could be employed. 
Previous studies looking at accelerated stability tests of LFIAs often incubate LFIA kits at 
37°C or 60°C for 1-4 weeks.  This has been shown to demonstrate similar results to the 
real-time stability tests where real-time stability can be estimated using the Arrhenius 
equation. Thus, an appropriate incubation period for the HemaTrace® kits should be 1-4 
weeks at experimental temperature conditions. 
 
3.3 Qualitative Assessment of HemaTrace with Temperature 
The sensitivity of the HemaTrace® kits can be monitored using similar qualitative 
protocols used in previous HemaTrace® studies. This can be done by testing the 
HemaTrace® kits against a dilution series of blood samples.24, 30-33 The minimum detection 
limit can be estimated by recording the most dilute sample with a positive HemaTrace® 
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result. The effects of temperature on the HemaTrace® kit can be monitored by observing 
if a change in the minimum detection limit is seen after incubation of the kits at 
experimental temperatures. 
 
However, one disadvantage of this qualitative method is that a weak positive band can be 
classified as positive or negative, depending on the interpretation of the observer. 
Secondly, for a qualitative study, the minimum detection limit is more accurately 
represented as a range rather than a specific value. For example, the minimum 
detectable limit for HemaTrace®, as reported by Swander and Stites33, was a 1:16 777 216 
dilution factor. The subsequent dilution factor of 1:33 554 432 produced a negative 
result. Therefore, the minimum detection limit lies between the two dilution factors. Thus 
it would be beneficial to be able to quantify the HemaTrace® results to objectively 
measure the minimum detection limit, which is stated in the Technical Information Sheet 
to be 0.05μg/mL.5 
 
3.4 Quantitative Assessment of HemaTrace with Temperature 
Quantitative measurements of the ABACard® HemaTrace® kits can be done similar to 
previous studies, using T/C ratio measurements. For the HemaTrace® kits, this could 
potentially be done by measuring the Test and Control band intensities using reflectance 
spectroscopy (Figure 17). However, the labelling molecule responsible for the appearance 
of the pink band is not publically known. Hence, the optical properties of the labelling 
molecule are not publically known. Furthermore, haemoglobin is a chromophore that 
when mixed in the HemaTrace® extraction buffer can result in various solution colours 
ranging from straw coloured to orange to red.31, 33 Thus, this could potentially lead to 
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background interference resulting in inaccurate spectroscopic measurements. Thus this 




Figure 17: Schematic of band intensity measurement using reflectance spectroscopy 
(Image from [45]). 
 
However, if this method is successful, this will allow the calculation of the Arrhenius 
equation to determine the rate of HemaTrace® degradation at a given temperature. This 
would be beneficial, as this will provide an indication toward the shelf life of the 






3.5 Miscellaneous Factors 
The experimental design aims to evaluate the effects of temperature on the HemaTrace® 
kits and any potential factors that may effect HemaTrace® efficacy will be controlled. 
Humidity has been shown to increase the rate of antibody degradation on antibodies 
stored on paper.43 Furthermore, pH and ionic strength variations can disrupt protein 
interactions due protein unfolding.54 Thus, these factors should be controlled to ensure 
that these factors do not complicate the interpretation of the HemaTrace® thermal 
stability results. 
 
Lastly, Atkinson et al, Johnston et al and Horjan et al24, 30-31 noted that aged bloodstains 
could produce false negatives. It was hypothesised that this is due to a reduction of 
protein solubility as the bloodstain ages. Thus, a HemaTrace® thermal stability study 
should standardise bloodstain age by using fresh blood samples. 
 
4.0 EXPERIMENTAL AIMS AND HYPOTHESIS 
From the research presented in this literature review, it has been demonstrated that 
elevated temperatures and prolonged exposure durations may result in a reduction in 
HemaTrace® kit efficacy. This is potentially due to antibody denaturation resulting in the 
inability of antibodies to bind to haemoglobin molecules in human blood samples. The 
occurrence of false negative HemaTrace® results could potentially lead to the exclusion of 
relevant forensic evidence. Thus, the experiment dictated by this literature review aims to 
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assess whether the elevated storage conditions experienced by the HemaTrace® kits 
could potentially result in false negatives. This will be done by testing two hypotheses: 
 
Hypothesis 1 
H0: Exposure of the HemaTrace® kits to elevated temperatures will not affect the 
        sensitivity of the kits. 
 
H1: Exposure of the HemaTrace® kits to elevated temperature will result in an 
        increase or decrease in the sensitivity of the kit. 
 
Hypothesis 2 
H0: The duration of elevated temperature exposure does not effect the sensitivity of  
       the HemaTrace® kits. 
H1: The duration of elevated temperature exposure will result in an increase or 




In conclusion, the ABACard® HemaTrace® kit is a sensitive kit that shows some cross 
reactivity with ferret and higher primate blood samples. Assessment of temperature 
studies on antibodies, showed that elevated temperature exposure of the HemaTrace® 
kits could result in antibody denaturation resulting in a decrease in antibody binding 
efficacy. This in turn would result in a decrease in overall kit efficacy which could 
potentially provide a suitable explanation for the HemaTrace® false negative results seen 
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in the northern regions of Western Australia. In order to test this, an accelerated stability 
test could be conducted to monitor the changes in HemaTrace® kit efficacy in response to 
prolonged temperature exposure. The literature pertaining to accelerated stability tests 
of other lateral flow immunochormatographic assays suggest that an increase in 
temperature and exposure time will result in a decrease in HemaTrace® kit efficacy. 
However, as the components of the HemaTrace® kit is not publically known, future 
research is required to test this hypothesis. The findings of such a study would inform 
forensic practitioners on recommended storage conditions for the HemaTrace® kits and 
to ensure that negative results found at a crime scene are true negatives and not due to 
the failure of the HemaTrace® kits. 
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The examination of bloodstains at a crime scene is a valuable tool for forensic 
investigations. One of the early steps in analysing a bloodstain is to first identify whether 
the stain is indeed blood and if it is of human origin. The ABAcard® HemaTrace® kit is a 
lateral flow immunochromatographic assay used by the Western Australia (WA) Police as a 
tool to identify human blood at crime scenes. However, WA Police officers have noted that 
ABAcard® HemaTrace® kits in the northern regions of WA have been producing false 
negative results. The current hypothesis for these occurrences is that the false negatives 
are due to the increased temperatures experienced in northern WA. Thus, this study 
aimed to evaluate the effects of elevated storage temperature on the efficacy of the 
ABAcard® HemaTrace® kits. This was done by testing ABAcard® HemaTrace® kits against 
blood samples diluted as a dilution series ranging from 1:10 to 1:10 000 000 after 
incubation at 40°C, 50°C and 60°C for a period of 4 weeks. Incubation of the ABAcard® 
HemaTrace® kits at 60°C for 2 weeks was enough to produce false negative results across 
the entire dilution series tested. A secondary aim of this study was to determine the 
duration the ABAcard® HemaTrace® would remain valid for at elevated temperatures. This 
study estimated that at 40°C, ABAcard® HemaTrace® kits would remain valid for only 70 
 3 
days. Overall, this study demonstrated that temperature does adversely affect the 
ABAcard® HemaTrace® kits and could provide a valid explanation for the false negative 
























Analysis of blood stains found at a violent crime scene can be used as an important 
investigative tool.1 DNA analysis2 can potentially identify individuals involved in the crime 
and Blood Pattern Analysis3 can be used for the reconstruction of a bloodshed event. As 
many substances share a similar appearance to blood, it is important that bloodstains 
found at a crime scene are correctly identified before further analysis is conducted.1 This is 
to prevent the loss of valuable time and resources on samples that may not have much 
evidentiary value. 
 
The ABAcard® HemaTrace® kit is a lateral flow immunochromatographic assay that targets 
human haemoglobin and is currently used by the Western Australia (WA) Police as a tool 
to identify human blood at crime scenes.4 The test procedure of a potential bloodstain 
involves the addition of the stain to an extraction buffer that facilitates haemolysis, 
followed by addition of the extract to the ABAcard® HemaTrace® kit. If human 
haemoglobin is present, the human haemoglobin will bind to mobile monoclonal 
antibodies-dye conjugates located in the absorbent test strip. This results in the formation 
of mobile antigen-antibody-dye complexes. The mobile complexes migrate along the test 
strip to a Test Area containing immobile polyclonal antihuman-Hb antibodies. The 
immobilised polyclonal antibodies bind to the mobile complexes to form an antibody-
antigen-antibody sandwich. This results in the accumulation of the conjugated dye at the 
Test Area resulting in a pink band. Excess mobile monoclonal antibody-dye conjugates 
migrate past the Test Area to a Control Area, where a second set of immobilised antibodies 
are present that bind to the excess mobile monoclonal antibodies. This results in the 
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accumulation of the conjugated dye at the Control Area. Thus, a second pink band is 
formed, which acts as an internal control for the ABAcard® HemaTrace® kit.5 
 
The results of ABAcard® HemaTrace® testing are interpreted qualitatively. A positive result 
is indicated by a band at the Test and Control area whilst a negative result is indicated by 
the absence of a band at the Test area and the presence of a band at the Control area.6 
However, a common feature noted for the ABAcard® HemaTrace® kit is that the kit suffers 
from the ‘high dose hook effect’, where high concentrations of haemoglobin result in 
ABAcard® HemaTrace® false negatives.7 
 
Reports from WA Police officers have noted that ABAcard® HemaTrace® kits in the 
northern regions of WA have been producing false negatives.8 This can be detrimental to 
an investigation as this may result in the exclusion of relevant forensic evidence. Blood 
deposited at a crime scene is potentially exposed to degradative conditions. Thus, it was 
hypothesised that the false negatives may be due to the degradation of the blood proteins 
as a result of the elevated temperatures experienced in northern WA.9 However, previous 
studies evaluating the effects of high temperature exposure to blood samples on ABAcard® 
HemaTrace® testing have reported that false negatives were only seen when blood 
samples were exposed to extreme temperatures of approximately 80°C.10 It is unlikely that 
this would be responsible for the false negative results obtained in northern WA as even 
surfaces such as asphalt rarely exceed 70°C.11 Thus, an alternative explanation is needed to 
account for the occurrences of these false negative results. 
 
Another factor that could potentially contribute to the appearance of the ABAcard® 
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HemaTrace® false negatives is that the ABAcard® HemaTrace® kits themselves are exposed 
to elevated temperatures. A study conducted by Dadour et al12 noted that the internal 
temperature of parked vehicles can potentially exceed the external ambient temperature 
by 20-30°C. Thus, ABAcard® HemaTrace® kits stored in police vehicles8 are potentially 
exposed to temperatures up to 60°C. This may potentially adversely affect the ABAcard® 
HemaTrace® kits, however, this has yet to be tested. 
 
As the ABAcard® HemaTrace® kit is a qualitative test, the thermal stability of the kit can be 
assessed by incubating the kits at various temperatures and testing the kits against a series 
of diluted blood samples. This would enable the examiner to monitor the sensitivity of the 
kits in response to elevated temperature exposure. However, in order to calculate the 
shelf life of the kits, quantitative data is needed.13 Previous studies looking at quantifying 
lateral flow immunochromatographic assays utilise the Test and Control band intensities to 
measure the concentration of a target molecule.14-17 These studies noted that the Test 
band intensity is proportional to the concentration of the target molecule.17 However, it 
was found that the Test band intensity alone displayed a large amount of variation as 
immunoreaction time, batch variability and pH and ionic strength of the sample can affect 
the Test band intensity.17,18 Thus, these studies used the Control band as a normalising 
factor, using the Test band intensity divided by the Control band intensity (T/C ratio) as a 
quantitative measurement of the immunoassay signal.14-20 Using the T/C ratio 
measurements, two previous studies have been able to calculate the shelf life of lateral 
flow immunochromatographic assays by assuming  that the degradation of the kits follow a 
zero order or first order reaction.21,22 
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Thus, this study aimed to evaluate the effects of temperature on the ABAcard® 
HemaTrace® kit by monitoring the sensitivity of the kits after exposure to temperatures of 
40°C, 50°C and 60°C for a period of 4 weeks. A secondary aim was to determine the 
duration the ABAcard® HemaTrace® kits would remain valid under elevated temperature 
conditions. This was done by performing a stability test on the ABAcard® HemaTrace® kits 
where shelf life was calculated using T/C ratio measurements and assuming the 
degradation of the kits followed first order reaction kinetics. 
 
MATERIALS AND METHODS 
A total of 147 commercially available ABAcard® HemaTrace® kits (Abacus Diagnostics Inc., 
West Hills, CA, USA) were evaluated in this study. Fresh blood samples were obtained via 
venepuncture from a healthy, non-smoking, 25 year old male. To simulate blood found at a 
crime scene, no anticoagulants were used. Immediately after incubation, blood samples 
were diluted in the ABAcard® HemaTrace® extraction buffer in a 10-fold serial dilution, 
resulting in dilution factors ranging from 1:10 to 1:10 000 000. Haemoglobin concentration 
of the diluted blood samples were estimated by measuring the haemoglobin content of 
the neat blood sample using a complete blood count (CBC), which was found to be 
152.5g/L. 
 
Qualitative Assessment of ABAcard® HemaTrace® 
A total of 126 ABAcard® HemaTrace® kits were used for the qualitative assessment of the 
kits. The ABAcard® HemaTrace® kits were incubated at 40°C, 50°C and 60°C in Hybridiser 
HB-1D (Techne®) incubator ovens. A control set of ABAcard® HemaTrace® kits were 
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incubated at room temperature (~22°C). Temperatures were monitored using Rowe 
Scientific Pty. Ltd Digital Thermometers and ABAcard® HemaTrace® kits were tested in 
duplicate at 0, 2 and 4 weeks against a blood sample dilution series ranging from 1:10 to 
1:10 000 000. 
 
Qualitative interpretation 
Prior to testing, ABAcard® HemaTrace® kits were left to cool at room temperature.  The 
ABAcard® HemaTrace® kits were tested according to the manufacturer’s protocol.6 Briefly, 
150μL of extracted blood sample was pipetted into the sample well and results were 
recorded after 10 minutes. A pink band at both the Test (T) and Control (C) region 
indicated a positive result. In order to minimise subjective interpretation of the ABAcard® 
HemaTrace® results, weak ‘T’ band intensities that were too faint to conclusively score and 
too faint to photograph, were categorised as ‘partial negatives’. A negative result was 
indicated by the absence of a pink band at the ‘T’ region with the presence of a band at the 
‘C’ region. A result was deemed inconclusive if no band appeared at the ‘C’ region 
regardless if a band was present or absent at the ‘T’ region.   
 
Measurement of ABAcard® HemaTrace® band intensities 
ABAcard® HemaTrace® ‘T’ and ‘C’ bands were imaged using a GS-900™ Calibrated 
Densitometer (BioRad). The ABAcard® HemaTrace® kits were scanned using the Reflective, 
Green Filter, Colloidal Gold setting with a resolution of 63.5 microns. The ‘T’ and ‘C’ bands 
were viewed using the Image Lab™ software (Version 6.0), where band intensities were 
measured by obtaining the area under the curve (Figure 1).  The ‘T’ band intensity divided 
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by the ‘C’ band intensity (T/C ratio) was used to quantitatively assess the performance of 




Figure 1: Measurement of Test and control band intensities to calculate T/C ratio. 
 
Stability test 
ABAcard® HemaTrace® kits were incubated at 40°C for 0, 1, 2, 5, 7 and 14 days. The 
ABAcard® HemaTrce® kits were tested in triplicate against a positive control at 1:10 000 
dilution. Test and Control band intensities were obtained and shelf life of the kits stored at 
40°C was estimated using a first order reaction kinetic equation shown below (Equation 1). 
 
                                                     Ln(T/C) = -kt + Ln(T/C)0                                                    (1) 
 
In this equation, T/C is the Test band divided by Control band intensity (T/C ratio) at time t, 

















Temperature and ABAcard® HemaTrace® sensitivity 
To assess the effects of temperature on the ABAcard® HemaTrace® kits, the sensitivity of 
the kits were evaluated after incubation at 40°C, 50°C and 60°C over a 4 week period.  
 
The control group, at room temperature, showed that the ABAcard® HemaTrace® kits 
produced consistent positive results within a dilution range of 1:100 to 1:100 000. At 
dilution factors of 1:10, the ‘high dose hook effect’ was seen, producing false negative 
results. Similarly, ABAcard® HemaTrace® kits tested against dilution factors of 1:1 000 000 
and 1:10 000 000 also produced false negative results. The effective working range of the 
control group remained consistent throughout the 4 week testing period (Table 1). 
 
Kits incubated at 40°C showed a similar effective range to the control group over the 4 
week period (Table 1). Consistent positive results were obtained from samples diluted 
from 1:100 to 1:100 000 at both 2 weeks and 4 weeks. 
 
Kits incubated at 50°C showed a gradual decrease in the effective range of the kits with 
time. At 2 weeks after incubation, the kits began producing unreliable results at dilution 
factors of 1:100. At 4 weeks after incubation, unreliable results were obtained at dilution 
factors of 1:100 and 1:100 000, thus effectively shrinking the effective range of the kits by 
two dilution factors (Table1).  
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Lastly, kits incubated at 60°C failed to produce any reliable positive results across the 
entire dilution series tested. A single weak positive result was seen after incubation for 2 
weeks when tested against a blood sample diluted to 1: 10 000. However, at 4 weeks post 
incubation, none of the kits produced a positive result (Table 1). 
 
In summary, within the 4 week test period, at temperatures of 50°C and above, an 
increase in temperature and exposure duration resulted in a decrease in the effective 
















Table 1: ABAcard® HemaTrace® results after incubation at room temperature, 40°C, 50°C 





0 2 weeks 4 weeks 
Replicate Replicate Replicate 
1 2 1 2 1 2 
~22°C (Room 
Temperature) 
1:10 - - - - +* -** 
1:100 +* +* + + + + 
1:1 000 + + + + + + 
1:10 000 + + + + + + 
1:100 000 + + + + + +* 
1:1 000 000 -** -** - -** +* - 
1:10 000 000 - - - - - - 
40°C 
1:10 n/a n/a - - - - 
1:100 n/a n/a + +* + + 
1:1 000 n/a n/a + + +* + 
1:10 000 n/a n/a + + + + 
1:100 000 n/a n/a + + + + 
1:1 000 000 n/a n/a - - - - 
1:10 000 000 n/a n/a - - - - 
50°C 
1:10 n/a n/a - - - -** 
1:100 n/a n/a +* -** + -** 
1:1 000 n/a n/a + + + + 
1:10 000 n/a n/a + + +* + 
1:100 000 n/a n/a +* +* -** +* 
1:1 000 000 n/a n/a - - - - 
1:10 000 000 n/a n/a - - - - 
60°C 
1:10 n/a n/a - - - - 
1:100 n/a n/a - - -** - 
1:1 000 n/a n/a - -** - - 
1:10 000 n/a n/a +* -** - - 
1:100 000 n/a n/a - - - - 
1:1 000 000 n/a n/a - - - - 
1:10 000 000 n/a n/a - - - - 
+     Positive ABAcard® HemaTrace® result 
-      Negative ABAcard® HemaTrace® result 
+*   Weak positive: Very faint band at Test Area 
-** Partial negative: Band present at the Test Area but too faint to confidently 
  classify as positive 




ABAcard® HemaTrace® Dose Response Curve 
In order to assess the applicability of using band intensities to quantitatively measure the 
ABAcard® HemaTrace® signal, Test and Control band intensities were obtained from 
ABAcard® HemaTrace® kits that were tested against a dilution series ranging from 1:10 to 
1:10 000 000. The T/C ratio of the kits showed an increase with haemoglobin 
concentration, reaching a peak at 15.25μg/mL of haemoglobin. At haemoglobin 
concentrations above 15.25μg/mL a decrease in the T/C ratio was observed, 




Figure 2: Dose response cure of ABAcard® HemaTrace® kits tested against a dilution series 
ranging from 1:10 dilution to 1:10 000 000 dilutions (Error bars pertain to the standard 
error of the mean). 
 
Stability test 
The thermal stability of the ABAcard® HemaTrace® kit was tested at 40°C for a period of 14 
days. It was noted that an increase in exposure time resulted in a decrease in the T/C ratio. 















Log (Hb concentration, μg/mL)
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ratio was plotted against time according to a first order reaction (Equation 1) (Figure 3). 
The gradient of the curve was taken as the rate constant (k), which was found to be 
0.0132day-1. Using Equation 1, it was estimated that the ABAcard® HemaTrace® kits would 
be valid for 70 days if stored at 40°C. However, it was noted that linear regression analysis 




Figure 3: Shelf life estimation of the ABAcard® HemaTrace® kits stored at 40°C using a first 
order reaction equation (Equation 1: Ln(T/C) = -kt + Ln(T/C)0) (Error bars pertain to the 
standard error of the mean). 
 
DISCUSSION 
The main objective of this study was to evaluate effects of elevated temperature exposure 
on the ABAcard® HemaTrace® kit. From the results, this study successfully demonstrated 
that elevated storage temperatures above 50°C and prolonged exposure durations 
adversely effected the ABAcard® HemaTrace® kits by reducing the effective working range 






















of the kits, resulting in the occurrences of false negatives. Furthermore, it was found that 
storing the ABAcard® HemaTrace® kits at 40°C reduced the kit shelf life to only 70 days. 
 
Thermal degradation of the ABAcard® HemaTrace® kit 
This study showed that elevated temperature has a degradative effect on the ABAcard® 
HemaTrace® kits. However, this study does not elucidate the mechanism behind the 
degradation. One possible explanation is that at these elevated temperatures, antibodies 
within the kits denature resulting in the inability of the antibodies to recognise their 
respective targets. This hypothesis is supported by antibody denaturation studies 
performed by Vemeer and Norde23 that showed that the segment that contains the 
antigen binding site, called the Fab segment, denatures at temperatures of approximately 
60°C. This is similar to what was seen in the quantitative test where at 60°C, ABAcard® 
HemaTrace® kits produced false negatives throughout the dilution series tested. Vemeer 
and Norde23 also noted that at 55°C, the Fab segment still denatures but at a much slower 
rate. Thus, this suggests that the level of antibody denaturation is dependent on both 
temperature and exposure time. This is similar to what was found for the kits incubated at 
50°C, where the effective working range of the kits diminished gradually with time (Table 
1). 
 
Multiple other factors could also be responsible for the thermal degradation of the 
ABAcard® HemaTrace® kit. A study by Wang et al21 noted that an increase in storage 
temperature could result in displacement of the labelled molecule conjugated to the 
mobile monoclonal antibodies. This too could result in a decrease in the ABAcard® 
HemaTrace® band intensities resulting in the occurrences of false negative results.24 Thus, 
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the mechanism responsible for ABAcard® HemaTrace® thermal degradation remains to be 
concluded. 
 
ABAcard® HemaTrace® shelf life calculation 
The stability test performed in this study estimated that ABAcard® HemaTrace® kits would 
only be valid for 70 days if stored at 40°C. However, it was noted that the linear regression 
analysis of the results showed a very low R-squared value (R2=0.5559) (Figure3). Thus, the 
shelf life estimation performed in this study may not be accurate. A possible explanation 
for this inaccuracy was that the incubation time of the blood samples in the ABAcard® 
HemaTrace® extraction buffer was not controlled according to the manufacturer’s 
guidelines. Blood samples were incubated in the extraction buffer for over 30 minutes in 
contrast to the 5 minute recommended incubation time noted by the manufacturers.6 An 
increase in the incubation time would provide more time for haemolysis and allow more 
time for the haemoglobin proteins to solubilise, which is required for antibody binding 
within the ABAcard® HemaTrace® kits. However, this may have instead contributed to the 
variability seen in the T/C ratio measurements. 
 
Another possible explanation for this inaccuracy is that the degradation of the ABAcard® 
HemaTrace® kit was assumed to follow first order reaction kinetics. Previous studies 
assessing the shelf life of lateral flow immunochromatogrphic assays estimate the shelf life 
using the Arrhenius equation thus suggesting that the degradation of the kit follows either 
zero order or first order reaction kinetics.25 However, the low R-squared value obtained in 
this study potentially indicates that the degradation of the ABAcard® HemaTrace® kit does 
not follow first order reaction kinetic (Figure 3). Thus, further study is required to 
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determine the degradative trend of the ABAcard® HemaTrace® kits to enable better shelf 
life estimations. 
 
ABAcard® HemaTrace® sensitivity 
The sensitivity of the ABAcard® HemaTrace® kits in the control group showed a similar 
limit of detection as described by the manufacturers, where at haemoglobin 
concentrations below 0.05μg/mL, ABAcard® HemaTrace® results became unreliable. 
However, this is in contrast to a study conducted by Horjan et al26, where positive results 
were obtained at dilutions of 1:10 000 000, corresponding to a haemoglobin concentration 
estimate of 0.013μg/mL. A potential explanation for this slight discrepancy could be that 
this study restricted the immunoreaction time of the kits to 10 minutes. This is in 
concordance with the Technical Information Sheet6 provided by the manufacturers that 
states that the maximum time for reading the ABAcard® HemaTrace® result is 10 minutes, 
after which non-specific binding could potentially results in false positive results. This was 
demonstrated in this study as negative results for kits tested at concentrations below 
0.05μg/mL did produce a positive result after the 10 minute immunoreaction time (results 
not shown). 
 
The dose response curve of the ABAcard® HemaTrace® kits indicates that T/C ratio 
measurements could potentially be used to quantify haemoglobin concentration (Figure 
2). This method has been used by multiple lateral flow immunochromatographic assays to 
quantify the concentration of a target molecule.14-16 Obtaining quantitative results in this 
manner could potentially increase the sensitivity of the kit and would eliminate the 
ambiguity associated with a qualitative test, where a weak positive can be classified as a 
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positive or negative depending on the interpretation of the observer. 14-16 However, this 
method requires further validation and thus warrants further research. 
 
Forensic Implications and recommended storage conditions 
Temperature studies conducted on parked vehicles have reported that the internal cabin 
temperature of a vehicle can exceed 60°C.12 The results of this study makes this finding 
particularly concerning as incubation of the ABAcard® HemaTrace® kits at 60°C caused the 
kits to become completely invalid at as early as 2 weeks. Furthermore, ABAcard® 
HemaTrace® kits can be stored for months prior to use.8 However, it should be noted that 
this study incubated the kits at a constant temperature throughout the testing period. In 
reality, temperatures experienced by the kits will be dependent on the diurnal changes in 
ambient temperature. Furthermore, Dadour et al12 noted that the internal temperature of 
a vehicle is influenced by the level of solar radiation exposure, car colour and level of 
ventilation. Thus, as multiple factors can affect the temperatures experienced within a 
vehicle, future studies evaluating the temperatures experienced in police vehicles would 
be beneficial to conclusively determine whether ABAcard® HemaTrace® kits stored in 
these vehicles are actually exposed to detrimental temperatures. 
 
The stability test performed in this study estimated that the ABAcard® HemaTrace® kits 
would only be valid for 70 days if stored at 40°C. In contrast, according to the 
manufacturers, the ABAcard® HemaTrace® kits should have a shelf life of at least a year if 
stored below 28°C.6 Thus, this demonstrates that even mild heating temperatures can 
affect the ABAcard® HemaTrace® kit by greatly reducing the shelf life of the kits. This too is 
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concerning as it is not uncommon for ambient temperatures to reach 40°C during the 
Australian summer months.9 
 
In summary, the main findings of this study demonstrate that forensic practitioners should 
adhere to the recommended storage conditions for the ABAcard® HemaTrace® kits more 
strictly. Thus, it is recommended that WA Police officers should refrain from storing the 
ABAcard® HemaTrace® kits in police vehicles. It is suggested that the kits should be stored 
indoors at room temperature away from sunlight exposure. When using the kits in the 
field, special care should be taken to protect the kits from elevated temperatures. Thus, 
kits used in the field should be placed in a thermally insulated container, such as a 
Styrofoam box; to protect the kits from elevated ambient temperatures especially during 
the summer months.9 The occurrences of false negatives can have serious implications for 
a forensic investigation and also in a court of law. Thus, the authors advise that forensic 
practitioners adhere to these guidelines to prevent future occurrences of ABAcard® 
HemaTrace® false negative results. 
 
Lastly, multiple other factors could contribute to the occurrence of an ABAcard® 
HemaTrace® false negative result.10,27 Previous studies have shown that humidity plays a 
role in antibody degradation28,29 and thus could also potentially effect ABAcard® 
HemaTrace® testing. Furthermore, the conditions at a crime scene are not controlled, 
thus, bloodstains at a crime scene could be exposed to degradative agents especially if a 
crime scene clean up has occurred. Although a previous study has noted the effect of 
sodium hypochlorite (bleach) as an oxidising agent on ABAcard® HemaTrace® testing27, the 
study did not look at how sodium hypochlorite affected the pH of the blood samples. 
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Factors such as this require further study as pH changes can disrupt antibody binding30, 
which could potentially effect ABAcard® HemaTrace® testing. 
 
CONCLUSION 
The purpose of this study was to evaluate the effects of temperature on the ABAcard® 
HemaTrace® kit by testing the ABAcard® HemaTrace® kits against a dilution series. It was 
found that an increase in storage temperature and exposure time resulted in a decrease in 
the effective working range of the ABAcard® HemaTrace® kits. Furthermore, the stability 
test performed at 40°C demonstrated that the shelf life of the ABAcard® HemaTrace® kits 
was greatly reduced in response to elevated storage temperatures. In conclusion, this 
study successfully demonstrated that an increase in storage temperature could potentially 
explain the false negative results seen in northern WA. This study also highlights the 
importance for forensic practitioners to adhere to the recommended storage guidelines, 
which recommend that ABAcard® HemaTrace® kits should be stored below 28°C. 
Therefore, it is advisable that WA Police officers should refrain from storing the ABAcard® 
HemaTrace® kits inside police vehicles. Furthermore, in the event that the ABAcard® 
HemaTrace® kits have to be removed from storage to be used at a crime scene, kits should 
be placed in a thermally insulated containers to prevent elevated temperature exposure, 
especially during the Australian summer months. Although this study has demonstrated 
the degradative effects of temperature on the ABAcard® HemaTrace® kits, multiple other 
factors could also contribute to the occurrences of false negatives, such as substrate 
effects and environmental factors. Thus, further research may be required to determine 
whether these other factors may also play a role in the production of ABAcard® 
HemaTrace® false negative results. 
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